Tijaria Polypipes has received a single order of Rs 35.30 crore for supply of HDPE &...
Reliance Industries' (RIL) telecom arm -- Reliance Jio Infocomm (Jio) -- has entered into...
Gold futures ended lower on Thursday due to cautious outlook ahead to the Federal Reserve...
Copper futures ended higher on Friday as concerns about the impact of trade tensions on...
28-Apr2018
Copper futures ended lower on Friday on account of a firm dollar, which makes metals expensive for holders of other currencies. Copper prices fell further on worries that the supply disruptions that buoyed prices last year from mining labor contract renegotiations and other conflicts with host governments haven't materialized yet in 2018, meaning the market could continue to be well supplied.
Copper futures for May delivery fell 2.2 percent to settle at $3.046 a pound on the Comex metals division of New York Mercantile Exchange. While, copper on the London Metal Exchange ended down 2.4 percent at $6,796 a metric ton.
Copper futures ended higher on Friday as concerns about the impact of trade tensions on the global economy continued to ease after tariffs announced this week were set at lower rates than had been expected......
Copper futures ended higher on Thursday, supported by a weaker US dollar, with the currency sliding to a seven-week low against a basket of major currencies. However, concerns over the health of the global......
Copper futures ended nearly flat on Wednesday as traders weighed the latest moves in the trade battle between United States and China. Though, weaker dollar against some major basket of currencies capped......
Tijaria Polypipes has received a single order of Rs 35.30 crore for supply of HDPE & PLB Ducts from Tata Projects. The same has to be executed within a period of 3 months. The company takes great......
Reliance Industries' (RIL) telecom arm -- Reliance Jio Infocomm (Jio) -- has entered into 5 year partnership with India's leading broadcaster, Star India to unleash a new era in sports entertainment. Jio......
Sun Pharmaceutical Industries has received the Australian Therapeutic Goods Administration (TGA) approval for its specialty product, ILUMYA (tildrakizumab) for the treatment of adults with moderate-to-severe......